Surgery Partners CS SGRY

$23.25 +7.50 (47.62%)

Valuation

Market cap
2,061,958,000
Revenue TTM
$3,308,700,000
Net income TTM
$-77,900,000
PE ratio
79.50
Forward PE
64.46
Profit margin
-2.35%
Debt to equity
1.21

Trading

Volume
58,818,699
Avg volume
3,454,606
Day's range
$22.94 – $23.29
Shares out
130,918,000
Stochastic %K
100%
Beta
1.90
Analysts
Strong Sell
Price target
$18.82

Price

Company profile

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments...

Show more

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Industry
Medical Care Facilities
Sector
Healthcare
Phone
615 234 5900
Website
https://www.surgerypartners.com
Address
340 Seven Springs Way, Suite 600, Brentwood, United States

Latest news

Stocktwits

Market_Pulse_Report Oct 27, 1:07 AM
$SGRY Check out this great video explaing what is going on here! https://youtu.be/ZkvMo_5Leq0
0 replies
topstockalerts Oct 26, 9:39 PM
Top Gainers $AZTR $CLRO $SGRY $RFAI $EFOI
0 replies
topstockalerts Oct 26, 8:48 PM
Surgery Partners agreed to be acquired by HealthSpan Partners, an affiliate of nonprofit healthcare system Bon Secours Mercy Health, in an all-cash transaction valued at approximately $5.7 billion in enterprise value. Shareholders other than Bain Capital affiliates will receive $23.50 per share, representing a 49% premium to the previous close of $15.75. Bain Capital, which owns approximately 39% of Surgery Partners’ outstanding shares, will roll its stake into the acquiring entity rather than sell, remaining a significant partner after closing. The deal follows a failed 2025 attempt by Bain to take the company private at a higher enterprise valuation, underscoring the strategic appeal of Surgery Partners’ network of more than 176 surgical centers and hospitals across 30 U.S. states. A law firm specializing in investor rights has also launched an investigation into whether the transaction adequately compensates shareholders. $SGRY
0 replies
bobocouncil Oct 26, 8:33 PM
$NFLX $DASH $SGRY $RRC $BOBO.X netflix -3%, doordash -6%, meanwhile sgry +47% and rrc +17%. bobo got the good seats for this one, pass the popcorn
0 replies
jdlman Oct 26, 7:52 PM
$SGRY love it
0 replies
topstockalerts Oct 26, 7:41 PM
Top Gainers $AZTR $SGRY $CLRO $MSGY $LUCD
0 replies
Paul_Laurent Oct 26, 7:32 PM
📊🔥 Top Gainers Update 💰🚨 RTH 3:30pm ET Focusing on movers with the strongest fresh catalysts: $SGRY +47.56% – Definitive $5.7B acquisition agreement with HealthSpan Partners. Most shareholders will receive $23.50 cash per share, a major premium to Friday’s close. $XTND +25.71% – Preliminary 9-month revenue of $24.5M–$26.5M already exceeds FY2025 revenue, while AI Robotics backlog reached ~$84M. $LUCD +27.54% – Medicare reimbursement for EsoGuard at $1,938.01 per test remains the core commercial catalyst, supporting broader adoption potential. $CLRO +52.62% – Momentum-driven micro-cap move tied to renewed speculation around the pending Cortigent combination; Nasdaq delisting risk remains important. $GCTK +98.40% – Continued high-volatility momentum around the Lōkahi Therapeutics combination, with no stronger fresh same-day company catalyst identified.
1 replies
TheProfitt Oct 26, 6:51 PM
$SGRY any odds this will be shorted at all?
1 replies